Your browser doesn't support javascript.
loading
Retrospective investigation of side effects and prognoses of moderate-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia that developed in patients with autoimmune diseases.
Shibata, Tomohiko; Tonooka, Kumiko; Tsuchida, Kosei; Mitomi, Hirofumi; Shibata, Toshiko; Katsuyama, Naooki.
Affiliation
  • Shibata T; Division of Rheumatology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital.
Nihon Rinsho Meneki Gakkai Kaishi ; 39(3): 213-8, 2016.
Article in Ja | MEDLINE | ID: mdl-27320937
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Pneumocystis / Autoimmune Diseases / Trimethoprim, Sulfamethoxazole Drug Combination / Immunocompromised Host Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: Ja Journal: Nihon Rinsho Meneki Gakkai Kaishi Journal subject: ALERGIA E IMUNOLOGIA Year: 2016 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Pneumocystis / Autoimmune Diseases / Trimethoprim, Sulfamethoxazole Drug Combination / Immunocompromised Host Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: Ja Journal: Nihon Rinsho Meneki Gakkai Kaishi Journal subject: ALERGIA E IMUNOLOGIA Year: 2016 Document type: Article Country of publication: